Pharmaceutical companies have more power than ever, and the American people are paying the price—too often with our lives …
” … as physicians, we have very little good information to go on. Even our most prestigious journals publish research based on falsified studies, according to Charles Seife, a journalism professor whose class spent a semester trying to figure out why the data don’t get corrected once research fraud comes to light. “As a result,” Seife writes, “nobody ever finds out which data is bogus, which experiments are tainted, and which drugs might be on the market under false pretenses.”
If no one knows which data is bogus, we obviously have a big problem in conventional medicine. Perhaps we shouldn’t be so focused on marketing shenanigans, and more concerned about the original study data before something becomes standard of care. Standard of care, of course, is driven by “research” that is incorporated into academic guidelines and is the basis of customer demand.”
In his recent investigation about the FDA, fraud and misconduct in scientific studies of medicine, Charles Seife – Journalist, author, NYU professor – and his students revealed that the FDA routinely fails to report evidence of fraud or misconduct when it inspects the way researchers conduct clinical trials, leaving the public unaware of which research is credible and which is not. Press Play> to listen to the recording.
Research Misconduct Identified by the US Food and Drug AdministrationOut of Sight, Out of Mind, Out of the Peer-Reviewed Literature, JAMA Intern Med. Published online, doi:10.1001/jamainternmed.2014.7774, February 09, 2015.
The FDA doesn’t tell you when it finds scientific fraud, theverge, February 9, 2015.
FDA fails to report fraud in clinical trials – study, Reuters, February 10, 2015.
Medical Fraud Missing From Public Record, sciencefriday, FEB. 13, 2015.